Notification
No new Notification messages
Garuda Construction And Engineering IPO is Open!
Apply for the Garuda Construction And Engineering IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
Trade Now, Pay Later with up to 4x Leverage
Never miss a good trading opportunity due to low funds with our MTF feature.
NSE BSE
syngene international ltd stock

SYNGENE INTERNATIONAL LTD Share Price

887.6 10.64 (1.21%)
Oct 09 2024 11:41 AM Healthcare NSE: SYNGENE

SYNGENE INTERNATIONAL LTD Share Price Update

As of the latest trading session, SYNGENE INTERNATIONAL LTD share price is currently at 887.6, which is up by 10.64 from its previous closing. Today, the stock has fluctuated between 878.10 and 893.80. Over the past year, SYNGENE INTERNATIONAL LTD has achieved a return of 11.46 %. In the last month alone, the return has been -2.79 %. Read More...

SYNGENE INTERNATIONAL LTD Performance

Day Range

Low878.10 High893.80
891.00

52 Week Range

Low 607.65 High 945.25
891.00

SYNGENE INTERNATIONAL LTD Share Price

10243

539268

SYNGENE

img img img img
No Data Available

Open Price

878.10

Prev. Close

876.95

Volume (Shares)

64914.00

Total traded value

578.38

Upper Circuit

956.20

Lower Circuit

782.40

Note: The current prices & values are delayed, Login to your account for live updates.

SYNGENE INTERNATIONAL LTD Fundamentals


(Standalone)

Market Cap (Cr) 35682.85
PE Ratio (TTM) 75.96
Book Value / Share 104.14
Beta 0.51
ROE 11.95%
EPS (TTM) 11.18
Dividend Yield 0.14%
Net Profit Qtr (Cr) 73.90

SYNGENE INTERNATIONAL LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars JUN 2024 (Values in Cr)
Revenue 726.50
Operating Expense 677.40
Net Profit 73.90
Net Profit Margin (%) 10.17
Earnings Per Share (EPS) 1.84
EBITDA 197.90
Effective Tax Rate (%) 25.20
Particulars MAR 2024 (Values in Cr)
Revenue 864.70
Operating Expense 669.60
Net Profit 189.80
Net Profit Margin (%) 21.94
Earnings Per Share (EPS) 4.73
EBITDA 314.60
Effective Tax Rate (%) 9.79
Particulars DEC 2023 (Values in Cr)
Revenue 791.90
Operating Expense 692.30
Net Profit 99.80
Net Profit Margin (%) 12.60
Earnings Per Share (EPS) 2.49
EBITDA 224.60
Effective Tax Rate (%) 19.96
Particulars SEP 2023 (Values in Cr)
Revenue 830.70
Operating Expense 713.60
Net Profit 101.60
Net Profit Margin (%) 12.23
Earnings Per Share (EPS) 2.53
EBITDA 230.20
Effective Tax Rate (%) 22.26
Particulars JUN 2023 (Values in Cr)
Revenue 715.80
Operating Expense 647.20
Net Profit 75.30
Net Profit Margin (%) 10.51
Earnings Per Share (EPS) 1.88
EBITDA 186.30
Effective Tax Rate (%) 17.70
Particulars MAR 2024 (Values in Cr)
Revenue 3203.10
Operating Expense 2722.70
Net Profit 466.50
Net Profit Margin (%) 14.56
Earnings Per Share (EPS) 11.62
EBITDA 955.69
Effective Tax Rate (%) 16.29
Particulars MAR 2023 (Values in Cr)
Revenue 3193.50
Operating Expense 2663.50
Net Profit 473.00
Net Profit Margin (%) 14.81
Earnings Per Share (EPS) 11.81
EBITDA 1005.20
Effective Tax Rate (%) 21.28
Particulars MAR 2022 (Values in Cr)
Revenue 2601.40
Operating Expense 2141.79
Net Profit 393.80
Net Profit Margin (%) 15.13
Earnings Per Share (EPS) 9.89
EBITDA 815.50
Effective Tax Rate (%) 18.24
Particulars MAR 2021 (Values in Cr)
Revenue 2179.40
Operating Expense 1811.60
Net Profit 403.70
Net Profit Margin (%) 18.52
Earnings Per Share (EPS) 10.15
EBITDA 769.59
Effective Tax Rate (%) 13.62
Particulars MAR 2020 (Values in Cr)
Revenue 2011.90
Operating Expense 1649.10
Net Profit 411.50
Net Profit Margin (%) 20.45
Earnings Per Share (EPS) 10.36
EBITDA 769.60
Effective Tax Rate (%) 20.20
Particulars MAR 2024 (Values in Cr)
Book Value / Share 105.92
ROE % 12.95
ROCE % 13.56
Total Debt to Total Equity 0.17
EBITDA Margin 31.36
Particulars MAR 2023 (Values in Cr)
Book Value / Share 90.13
ROE % 13.43
ROCE % 13.64
Total Debt to Total Equity 0.27
EBITDA Margin 31.49
Particulars MAR 2022 (Values in Cr)
Book Value / Share 82.28
ROE % 12.94
ROCE % 11.77
Total Debt to Total Equity 0.31
EBITDA Margin 31.42
Particulars MAR 2021 (Values in Cr)
Book Value / Share 70.54
ROE % 16.21
ROCE % 13.54
Total Debt to Total Equity 0.33
EBITDA Margin 35.32
Particulars MAR 2020 (Values in Cr)
Book Value / Share 54.40
ROE % 17.30
ROCE % 15.06
Total Debt to Total Equity 0.38
EBITDA Margin 34.63
Particulars MAR 2024 (Values in Cr)
Book Value / Share 104.27
ROE % 11.95
ROCE % 12.51
Total Debt to Total Equity 0.12
EBITDA Margin 29.84
Particulars MAR 2023 (Values in Cr)
Book Value / Share 90.16
ROE % 13.69
ROCE % 14.07
Total Debt to Total Equity 0.24
EBITDA Margin 31.48
Particulars MAR 2022 (Values in Cr)
Book Value / Share 82.14
ROE % 12.89
ROCE % 11.72
Total Debt to Total Equity 0.31
EBITDA Margin 31.35
Particulars MAR 2021 (Values in Cr)
Book Value / Share 70.46
ROE % 16.17
ROCE % 13.50
Total Debt to Total Equity 0.33
EBITDA Margin 35.31
Particulars MAR 2020 (Values in Cr)
Book Value / Share 54.35
ROE % 17.28
ROCE % 15.02
Total Debt to Total Equity 0.38
EBITDA Margin 34.57
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 563.50
Total Assets 6151.60
Total Liabilities 6151.60
Total Equity 4257.80
Share Outstanding 402015000
Price to Book Ratio 6.73
Return on Assets (%) 8.29
Return on Capital (%) 11.59
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 531.70
Total Assets 5831.00
Total Liabilities 5831.00
Total Equity 3618.00
Share Outstanding 401434500
Price to Book Ratio 6.59
Return on Assets (%) 7.96
Return on Capital (%) 11.07
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 517.90
Total Assets 5563.80
Total Liabilities 5563.80
Total Equity 3297.60
Share Outstanding 400796500
Price to Book Ratio 7.27
Return on Assets (%) 7.11
Return on Capital (%) 9.68
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 642.60
Total Assets 4883.20
Total Liabilities 4883.20
Total Equity 2821.40
Share Outstanding 400000000
Price to Book Ratio 7.71
Return on Assets (%) 8.29
Return on Capital (%) 11.27
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 281.50
Total Assets 4162.90
Total Liabilities 4162.90
Total Equity 2175.80
Share Outstanding 400000000
Price to Book Ratio 4.44
Return on Assets (%) 9.89
Return on Capital (%) 16.59
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 528.20
Total Assets 5833.90
Total Liabilities 5833.90
Total Equity 4191.50
Share Outstanding 402015000
Price to Book Ratio 6.73
Return on Assets (%) 7.99
Return on Capital (%) 10.77
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 509.30
Total Assets 5848.00
Total Liabilities 5848.00
Total Equity 3618.90
Share Outstanding 401434500
Price to Book Ratio 6.59
Return on Assets (%) 8.08
Return on Capital (%) 11.28
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 515.10
Total Assets 5560.80
Total Liabilities 5560.80
Total Equity 3292.00
Share Outstanding 400796500
Price to Book Ratio 7.27
Return on Assets (%) 7.08
Return on Capital (%) 9.65
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 638.20
Total Assets 4877.50
Total Liabilities 4877.50
Total Equity 2818.30
Share Outstanding 400000000
Price to Book Ratio 7.71
Return on Assets (%) 8.27
Return on Capital (%) 11.24
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 280.30
Total Assets 4162.00
Total Liabilities 4162.00
Total Equity 2174.10
Share Outstanding 400000000
Price to Book Ratio 4.44
Return on Assets (%) 9.88
Return on Capital (%) 16.57
Particulars MAR 2024 (Values in Cr)
Net Income 510.00
Cash from Operations 1167.20
Cash from Investing -495.60
Cash from Financing -551.50
Net change in Cash -5.00
Free Cash Flow 1659.20
Particulars MAR 2023 (Values in Cr)
Net Income 464.40
Cash from Operations 960.30
Cash from Investing -656.40
Cash from Financing -342.50
Net change in Cash -175.40
Free Cash Flow 1466.90
Particulars MAR 2022 (Values in Cr)
Net Income 395.80
Cash from Operations 686.40
Cash from Investing -611.50
Cash from Financing -31.30
Net change in Cash -62.20
Free Cash Flow 1161.70
Particulars MAR 2021 (Values in Cr)
Net Income 404.90
Cash from Operations 784.80
Cash from Investing -628.10
Cash from Financing 58.00
Net change in Cash 131.10
Free Cash Flow 1225.60
Particulars MAR 2020 (Values in Cr)
Net Income 412.10
Cash from Operations 784.20
Cash from Investing -428.40
Cash from Financing -225.50
Net change in Cash 23.20
Free Cash Flow 1414.20
Particulars MAR 2024 (Values in Cr)
Net Income 466.50
Cash from Operations 1011.80
Cash from Investing -383.50
Cash from Financing -536.30
Net change in Cash -6.40
Free Cash Flow 1362.69
Particulars MAR 2023 (Values in Cr)
Net Income 473.00
Cash from Operations 972.10
Cash from Investing -688.20
Cash from Financing -340.20
Net change in Cash -190.00
Free Cash Flow 1493.50
Particulars MAR 2022 (Values in Cr)
Net Income 393.80
Cash from Operations 686.40
Cash from Investing -611.50
Cash from Financing -31.30
Net change in Cash -60.60
Free Cash Flow 1161.70
Particulars MAR 2021 (Values in Cr)
Net Income 403.70
Cash from Operations 780.80
Cash from Investing -628.10
Cash from Financing 58.00
Net change in Cash 127.90
Free Cash Flow 1221.60
Particulars MAR 2020 (Values in Cr)
Net Income 411.50
Cash from Operations 783.80
Cash from Investing -428.40
Cash from Financing -225.50
Net change in Cash 23.50
Free Cash Flow 1413.80
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6774.80 94.03 14.06 97411.23 4727.00 / 7319.95
FORTIS MALAR HOSPITALS LIMITED 56.82 0.00 0.97 106.49 44.00 / 107.94
SHREE PACETRONIX LTD. 151.80 19.07 4.19 54.64 138.00 / 391.90
TRANSGENE BIOTEK LTD. 7.58 0.00 5.36 57.43 3.84 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6774.80 92.95 12.63 97411.23 4727.00 / 7319.95
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 37.95 0.00 -86.85 28.35 23.00 / 54.65
KOVAI MEDICAL CENTER & HOSPITA 5362.75 30.17 6.60 5866.85 2377.20 / 5770.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 879.40
  • 26 Days 888.30
  • 10 Days 882.70
  • 50 Days 865.50
  • 12 Days 885.30
  • 100 Days 809.90
  • 20 Days 890.60
  • 200 Days 712.30
865.10
PIVOT
First Resistance 879.15
Second Resistance 889.00
Third Resistance 903.05
First Support 855.25
Second Support 841.20
Third Support 831.35
RSI 29.88
MACD -1.61
Commodity Channel Index (CCI) -149.42
ADX 29.73
Williams % R -80.25

Over 1 Month

down

-2.79

Over 3 Months

down

18.80

Over 6 Months

down

19.24

Over 1 Year

down

11.46

Over 3 Years

down

11.82

Over 5 Years

down

23.21

SYNGENE INTERNATIONAL LTD Future

Future: Price

31 Oct
888.25
28 Nov
889.90
25 May
0 100 200 300 400 500 600

Discount/Premium

31 Oct
1.75
28 Nov
3.40
25 May
0 1 2 3 4 5 6 7

Active Calls

920.0
164
900.0
133
880.0
55
25 May
0 500 1000 1500 2000 2500 3000

Active Puts

850.0
39
820.0
22
800.0
19
25 Jul
0 500 1000 1500 2000 2500

SYNGENE INTERNATIONAL LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
11.01
Promoter Holdings
54.72
FII
20.63
DII
13.63
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Biocon Limited Shareholding of Promoter and Promoter Group 2.19185608E8 54.45
Icici Prudential Large & Mid Cap Fund Public Shareholding 2.5209081E7 6.26
Government Of Singapore Public Shareholding 1.1837989E7 2.94
Government Pension Fund Global Public Shareholding 7942515.0 1.97
Uti-unit Linked Insurance Plan Public Shareholding 7382621.0 1.83
Nippon Life India Trustee Ltd-a/c Nippon India Pha Public Shareholding 6211551.0 1.54
Mirae Asset Focused Fund Public Shareholding 5676455.0 1.41
Lici New Endowment Plus-growth Fund Public Shareholding 4924468.0 1.22
Kotak Funds - India Midcap Fund Public Shareholding 4530124.0 1.13
Biocon Limited Employee Welfare Trust (murali Krishnan K N And K Nanda Kumar) Shareholding of Promoter and Promoter Group 1053633.0 0.26
Kiran Mazumdar Shaw Shareholding of Promoter and Promoter Group 21964.0 0.01
Dev Mazumdar Shareholding of Promoter and Promoter Group 13686.0 0.0
Biocon Research Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Ravi Rasendra Mazumdar Shareholding of Promoter and Promoter Group 8806.0 0.0

SYNGENE INTERNATIONAL LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-06-30 0.5 Final 2023-06-30 Equity shares 2023-06-30 0.75 Special 2023-06-30 Equity shares 2022-06-30 0.5 Final 2022-07-01 Equity shares 2022-06-30 0.5 Special 2022-07-01 Equity shares 2019-07-16 0.5 Final 2019-07-17 Equity shares 2018-07-17 1.0 Final 2018-07-18 Equity shares 2017-07-20 1.0 Final 2017-07-21 Equity shares 2016-03-17 1.0 Interim 2016-03-19 Equity shares
Ex-Date Ex-Bonus Ratio
2019-06-12 2019-06-11 1:1
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About SYNGENE INTERNATIONAL LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by SYNGENE INTERNATIONAL LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Syngene International Ltd?

Answer Field

The share price of Syngene International Ltd for NSE is ₹ 887.6 and for BSE is ₹ 886.8.

What is the Market Cap of Syngene International Ltd?

Answer Field

The market cap of Syngene International Ltd for NSE is ₹ 3,56,82.85 Cr. and for BSE is ₹ 3,56,50.69 Cr. as of now.

What is the 52 Week High and Low of Syngene International Ltd?

Answer Field

The 52 Week High and Low of Syngene International Ltd for NSE is ₹ 945.25 and ₹ 607.65 and for BSE is ₹ 945.75 and ₹ 608.00.

How to Buy Syngene International Ltd share?

Answer Field

You can trade in Syngene International Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Syngene International Ltd?

Answer Field

The 1 year returns on the stock has been 12.44%.

What is the Current Share Price of Syngene International Ltd?

Answer Field

Syngene International Ltd share price is for NSE ₹ 887.6 & for BSE ₹ 886.8 as on Oct 09 2024 11:41 AM.

What is the Market Cap of Syngene International Ltd Share?

Answer Field

The market cap of Syngene International Ltd for NSE ₹ 3,56,82.85 & for BSE ₹ 3,56,50.69 as on Oct 09 2024 11:41 AM.

What is the P/E Ratio of Syngene International Ltd Share?

Answer Field

As on Oct 09 2024 11:41 AM the price-to-earnings (PE) ratio for Syngene International Ltd share is 75.96.

What is the PB ratio of Syngene International Ltd Share?

Answer Field

As on Oct 09 2024 11:41 AM, the price-to-book (PB) ratio for Syngene International Ltd share is 104.14.

How to Buy Syngene International Ltd Share?

Answer Field

You can trade in Syngene International Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Syngene International Ltd Share on Bajaj Broking App?

Answer Field

To buy Syngene International Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Syngene International Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader